(Q33260784)

24 July 2017

PDGFR-alpha as a potential therapeutic target in uterine sarcomas (English)

1 reference

24 July 2017

Adams SF

1

1 reference

24 July 2017

Hickson JA

2

1 reference

24 July 2017

Hutto JY

3

1 reference

24 July 2017

Montag AG

4

1 reference

24 July 2017

Lengyel E

5

1 reference

24 July 2017

Yamada SD

6

1 reference

24 July 2017

language of work or name

English

0 references

publication date

17 October 2006

1 reference

24 July 2017

1 reference

24 July 2017

104

1 reference

24 July 2017

3

1 reference

24 July 2017

524-528

1 reference

Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989-1999.

24 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.09.013

Pathologic variables and adjuvant therapy as predictors of recurrence and survival for patients with surgically evaluated carcinosarcoma of the uterus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.09.013

Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.09.013

Signal transduction pathways in sarcoma as targets for therapeutic intervention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.09.013

Inhibition of KIT tyrosine kinase activity: a novel molecular approach to the treatment of KIT-positive malignancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.09.013

PDGFRA activating mutations in gastrointestinal stromal tumors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.09.013

Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.09.013

An immunohistochemical analysis of endometrial stromal and smooth muscle tumors of the uterus: a study of 54 cases emphasizing the importance of using a panel because of overlap in immunoreactivity for individual antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.09.013

Uterine epithelioid leiomyosarcomas with clear cells: reactivity with HMB-45 and the concept of PEComa.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.09.013

Prevalence of KIT expression in human tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.09.013

A phase II trial of cisplatin, ifosfamide, and mesna in patients with advanced or recurrent uterine malignant mixed müllerian tumors with evaluation of potential molecular targets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.09.013

Mutations in exon 11 of c-Kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.09.013

Immunohistochemical evaluation of KIT expression in sarcomas of the gynecologic region

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.09.013

The proto-oncogene c-kit is expressed in leiomyosarcomas of the uterus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.09.013

Clinicopathological analysis of c-kit expression in carcinosarcomas and leiomyosarcomas of the uterine corpus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.09.013

Uterine sarcomas express KIT protein but lack mutation(s) in exon 11 or 17 of c-KIT

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.09.013

COX-2, c-KIT and HER-2/neu expression in uterine carcinosarcomas: prognostic factors or potential markers for targeted therapies?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.09.013

c-Kit expression in patients with uterine leiomyosarcomas: a potential alternative therapeutic treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.09.013

A PDGFRA promoter polymorphism, which disrupts the binding of ZNF148, is associated with primitive neuroectodermal tumours and ependymomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.09.013

A role of PDGFRalpha in basal cell carcinoma proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.09.013

KIT and platelet-derived growth factor receptor alpha tyrosine kinase gene mutations and KIT amplifications in human solid tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.09.013

10.1016/J.YGYNO.2006.09.013

7 January 2021

Identifiers

DOI

1 reference

24 July 2017

1 reference